Skip to main content
Contact Us
Subscribe
E-Edition
43°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Inari Medical Inc
(NQ:
NARI
)
49.75
+0.75 (+1.53%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Inari Medical Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Inari Medical, Inc. (NARI) on Behalf of Investors
March 06, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
NARI INVESTOR NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
March 06, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
NARI INVESTOR NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
March 06, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 06, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Inari Medical,...
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Critical Insights From Inari Medical Analyst Ratings: What You Need To Know
February 29, 2024
Via
Benzinga
Recap: Inari Medical Q4 Earnings
February 28, 2024
Via
Benzinga
Inari Medical Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
January 23, 2024
Via
Benzinga
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Inari Medical, Inc. (NARI) on Behalf of Investors
March 06, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Inari Medical, Inc. (NARI) on Behalf of Investors
March 06, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox Encourages Inari Medical, Inc Investors with Significant Losses to Contact the Firm
March 06, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox Encourages Inari Medical, Inc Investors with Significant Losses to Contact the Firm
March 06, 2024
NEW YORK, NY - (NewMediaWire) - March 6, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)...
Via
TheNewswire.com
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
March 05, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Inari Medical, Inc. (NARI)
March 01, 2024
From
Kirby McInerney LLP
Via
Business Wire
INARI MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Inari Medical, Inc. on Behalf of Inari Medical Stockholders and Encourages Investors to Contact the Firm
February 29, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation – NARI
February 29, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
Inari Medical (NASDAQ: NARI): Kaplan Fox Investigates Potential Securities Fraud at Inari Medical
February 29, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Exposures
Legal
Inari Medical (NASDAQ: NARI): Kaplan Fox Investigates Potential Securities Fraud at Inari Medical
February 29, 2024
NEW YORK, NY - (NewMediaWire) - February 29, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the...
Via
TheNewswire.com
Topics
Fraud
Exposures
Legal
Shoals Technologies Posts Weak Q4 Results, Joins Butterfly Network, Schrödinger And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
February 29, 2024
U.S. stock futures were lower this morning, with the Dow futures trading lower by over 100 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 29, 2024
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.
Via
Benzinga
Inari Medical Reports Fourth Quarter 2023 Financial Results
February 28, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
February 14, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
5 medical stocks growing earnings by triple digits
February 06, 2024
There is a little known way to pick stocks like the pros do, and today's exercise points you to five high-probability winners in a sector that's quickly turning
Via
MarketBeat
Topics
Economy
Exposures
Economy
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
January 23, 2024
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth.
Via
Benzinga
Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance
January 09, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 20, 2023
From
Inari Medical, Inc.
Via
GlobeNewswire
Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT)
November 27, 2023
Clinical study randomizing up to 1,200 patients designed to help change guidelines in treating intermediate-risk Pulmonary Embolism (PE) patients globally
From
Inari Medical, Inc.
Via
GlobeNewswire
Inari Medical Closes Acquisition of LimFlow
November 15, 2023
From
Inari Medical, Inc.
Via
GlobeNewswire
After blowout earnings, Integer may be headed to new highs
November 07, 2023
A growth strategy that includes both in-house expansion and acquisition activity could keep Integer Holdings Corporation's run going well into 2024.
Via
MarketBeat
Topics
Economy
Exposures
Supply Chain
Inari Medical to Present at Upcoming Investor Conferences
November 02, 2023
From
Inari Medical, Inc.
Via
GlobeNewswire
Inari Medical Reports Third Quarter 2023 Financial Results
November 01, 2023
From
Inari Medical, Inc.
Via
GlobeNewswire
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 02, 2023
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.